COCH
Basic information
Region (hg38): 14:30874514-30895065
Previous symbols: [ "DFNA31", "DFNA9" ]
Links
Phenotypes
GenCC
Source:
- autosomal dominant nonsyndromic hearing loss (Supportive), mode of inheritance: AD
- nonsyndromic genetic hearing loss (Definitive), mode of inheritance: AD
- autosomal dominant nonsyndromic hearing loss 9 (Strong), mode of inheritance: AD
- hearing loss, autosomal recessive 110 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal recessive 110 | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language developmen | Audiologic/Otolaryngologic | 8817345; 9806553; 10400989; 14512963; 16261627; 18312449; 19161137; 20447147; 21046548; 21052762; 21774451; 22610276; 22931125; 29449721 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (7 variants)
- Autosomal dominant nonsyndromic hearing loss 9 (6 variants)
- Hereditary hearing loss and deafness (2 variants)
- Rare genetic deafness (2 variants)
- Bilateral sensorineural hearing impairment (1 variants)
- Nonsyndromic genetic hearing loss (1 variants)
- Hearing loss, autosomal recessive 110 (1 variants)
- Hearing impairment (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the COCH gene is commonly pathogenic or not. These statistics are base on transcript: . Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 32 | ||||
missense | 97 | 120 | ||||
nonsense | 7 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
Total | 11 | 12 | 103 | 29 | 9 |
Highest pathogenic variant AF is 0.0000131394
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
COCH | protein_coding | protein_coding | ENST00000396618 | 11 | 20552 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.24e-7 | 0.946 | 125687 | 0 | 61 | 125748 | 0.000243 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.676 | 264 | 297 | 0.890 | 0.0000148 | 3612 |
Missense in Polyphen | 99 | 112.74 | 0.87812 | 1481 | ||
Synonymous | -0.900 | 118 | 106 | 1.11 | 0.00000536 | 1088 |
Loss of Function | 1.90 | 15 | 25.3 | 0.593 | 0.00000143 | 284 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000535 | 0.000535 |
Ashkenazi Jewish | 0.000595 | 0.000595 |
East Asian | 0.000870 | 0.000870 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000151 | 0.000149 |
Middle Eastern | 0.000870 | 0.000870 |
South Asian | 0.000261 | 0.000229 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the control of cell shape and motility in the trabecular meshwork. {ECO:0000269|PubMed:21886777}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 9 (DFNA9) [MIM:601369]: A form of non-syndromic hearing loss characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Hearing loss is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers. {ECO:0000269|PubMed:10400989, ECO:0000269|PubMed:11295836, ECO:0000269|PubMed:12928864, ECO:0000269|PubMed:14512963, ECO:0000269|PubMed:16835921, ECO:0000269|PubMed:17561763, ECO:0000269|PubMed:18312449, ECO:0000269|PubMed:22610276, ECO:0000269|PubMed:22931125, ECO:0000269|PubMed:23993205, ECO:0000269|PubMed:25388789, ECO:0000269|PubMed:9806553, ECO:0000269|PubMed:9931344}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.238
- rvis_EVS
- 0.29
- rvis_percentile_EVS
- 71.5
Haploinsufficiency Scores
- pHI
- 0.533
- hipred
- Y
- hipred_score
- 0.501
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.545
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Coch
- Phenotype
- normal phenotype; hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- growth plate cartilage chondrocyte morphogenesis;sensory perception of sound;regulation of cell shape;defense response to bacterium;positive regulation of innate immune response
- Cellular component
- extracellular space;extracellular matrix;collagen-containing extracellular matrix
- Molecular function
- protein binding;collagen binding